Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4215
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hall, C. | en |
dc.contributor.author | Nourse, C. | en |
dc.contributor.author | Murphy, D. | en |
dc.contributor.author | Gibbons, M. | en |
dc.date.accessioned | 2022-11-07T23:50:32Z | - |
dc.date.available | 2022-11-07T23:50:32Z | - |
dc.date.issued | 2015 | en |
dc.identifier.citation | 109, (4), 2015, p. 280-282 | en |
dc.identifier.other | RIS | en |
dc.identifier.uri | http://dora.health.qld.gov.au/qldresearchjspui/handle/1/4215 | - |
dc.description.abstract | Background: Limited data regarding prevalence of hepatitis B virus infection in Timor-Leste exist. Methods: An observational study of hepatitis B surface antigen (HBsAg) results of women delivering at Bairo Pite Clinic in Dili, Timor-Leste was carried out. Results: Of the 781 women included in the study, 80.5% (626/777) of women who had accessed antenatal care had been tested for HBsAg, of whom 2.2% (14/626) were positive. Of the remaining women, 83.2% (129/155) received a test at the time of delivery, of whom 5.4% (7/129) were positive. Overall prevalence of HBsAg positivity was 2.8% (21/755). Conclusions: Further studies are urgently needed to establish the prevalence of HBV infection in Timor-Leste, particularly in pregnant women. Findings from this study suggest that routine HBV immunisation of newborns should be instituted promptly.L6064543632015-10-20 <br />2021-07-13 <br /> | en |
dc.language.iso | en | en |
dc.relation.ispartof | Transactions of the Royal Society of Tropical Medicine and Hygiene | en |
dc.title | Prevalence of hepatitis b infection in women delivering at a community health centre in dili, timor-leste and discussion of programmatic challenges | en |
dc.type | Article | en |
dc.identifier.doi | 10.1093/trstmh/tru207 | en |
dc.subject.keywords | hepatitis B | en |
dc.subject.keywords | human | en |
dc.subject.keywords | immunization | en |
dc.subject.keywords | major clinical study | en |
dc.subject.keywords | observational study | en |
dc.subject.keywords | pregnant woman | en |
dc.subject.keywords | prenatal care | en |
dc.subject.keywords | hepatitis B vaccine | en |
dc.subject.keywords | Timor-Leste | en |
dc.subject.keywords | vertical transmission | en |
dc.subject.keywords | hepatitis B antibodyhepatitis B surface antigen | en |
dc.subject.keywords | prevalence | en |
dc.subject.keywords | article | en |
dc.subject.keywords | obstetric delivery | en |
dc.subject.keywords | female | en |
dc.relation.url | https://www.embase.com/search/results?subaction=viewrecord&id=L606454363&from=exporthttp://dx.doi.org/10.1093/trstmh/tru207 | | en |
dc.identifier.risid | 885 | en |
dc.description.pages | 280-282 | en |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
Appears in Sites: | Children's Health Queensland Publications |
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.